DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Halozyme Therapeutics
HALO
Teradata Corp
TDC
Cars.com
CARS
Collegium Pharmaceutical
COLL
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -199.45%-3.41M | 14.64%10.85M | 584.58%7.99M | -92.72%6.06M | -695.54%-8M | 251.64%3.43M | -61.04%9.46M | -97.94%1.17M | -24.76%83.25M | -93.82%1.34M |
Net income from continuing operations | 2.17%-35.41M | 8.48%-33.48M | 4.62%-33.9M | 47.80%-149.72M | 0.85%-41.4M | 56.90%-36.19M | 75.83%-36.58M | -263.20%-35.55M | -339.67%-286.84M | -166.07%-41.76M |
Operating gains losses | -14.35%-19.1M | -46.11%-20.24M | -14.39%-18.26M | -383.26%-59.17M | -2,749.55%-12.65M | -192.35%-16.7M | -357.49%-13.85M | -649.08%-15.96M | 139.43%20.89M | 99.05%-444K |
Depreciation and amortization | -2.55%41.95M | -4.15%42.3M | -4.76%42.51M | 13.17%175.2M | -5.93%43.38M | -10.02%43.05M | 14.23%44.13M | 100.94%44.64M | 215.20%154.81M | 253.46%46.11M |
Other non cash items | 37.73%14.56M | 32.60%14.08M | 13.71%11.42M | -53.43%42.08M | 309.05%10.85M | -69.29%10.57M | -67.88%10.62M | -50.34%10.04M | 4,675.19%90.36M | 816.76%2.65M |
Change In working capital | -474.14%-6.41M | 84.56%7.2M | 274.62%5.23M | -223.91%-6.45M | -38.70%-9.07M | 110.25%1.71M | 165.03%3.9M | -110.98%-2.99M | 65.90%-1.99M | 20.63%-6.54M |
-Change in receivables | -1,492.82%-2.72M | -71.30%949K | 2,781.40%6.49M | 107.35%1.44M | 44.80%-1.82M | 103.06%195K | 138.35%3.31M | 81.51%-242K | -36,388.89%-19.6M | 7.67%-3.3M |
-Change in payables and accrued expense | 7.86%11.99M | 71.45%-1.43M | -42.28%2.71M | -63.66%2.06M | 24.24%-8.76M | 182.18%11.12M | -215.71%-5M | -82.23%4.7M | 133.40%5.67M | -3,871.13%-11.56M |
-Change in other current assets | -63.41%-15.68M | 37.34%7.67M | 46.68%-3.97M | -183.40%-9.95M | -81.87%1.51M | -215.49%-9.6M | -45.88%5.59M | 50.40%-7.45M | 243.35%11.93M | 404.95%8.32M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -199.45%-3.41M | 14.64%10.85M | 584.58%7.99M | -92.72%6.06M | -695.54%-8M | 251.64%3.43M | -61.04%9.46M | -97.94%1.17M | -24.76%83.25M | -93.82%1.34M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 9.74%15.4M | 106.46%16.42M | -224.75%-11.77M | 101.97%67.74M | 225.30%36.32M | 134.22%14.03M | -69.95%7.95M | 100.27%9.44M | -15,163.91%-3.45B | -92.93%11.17M |
Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Net investment purchase and sale | 12.23%17.94M | 56.00%17.89M | -174.28%-9.64M | -59.58%56.92M | --16.49M | --15.98M | -54.23%11.47M | -88.79%12.98M | --140.79M | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 9.74%15.4M | 106.46%16.42M | -224.75%-11.77M | 101.97%67.74M | 225.30%36.32M | 134.22%14.03M | -69.95%7.95M | 100.27%9.44M | -15,163.91%-3.45B | -92.93%11.17M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -5.53%-5.63M | -110.83%-5.18M | 12.18%-5.47M | -99.10%31.14M | -418.10%-5.1M | 98.03%-5.33M | 235.62%47.79M | -100.16%-6.22M | 2,836.25%3.47B | 100.82%1.6M |
Net issuance payments of debt | -3.74%-4.55M | -109.03%-4.51M | 19.24%-4.47M | -98.86%35.58M | 19.24%-4.43M | 97.18%-4.39M | 1,028.11%49.92M | -100.17%-5.53M | 8,138.28%3.13B | 96.81%-5.48M |
Net common stock issuance | -74.48%-253K | 25.00%-9K | -1,533.33%-49K | 32.64%-163K | 0.00%-3K | 37.50%-145K | -71.43%-12K | ---3K | 73.75%-242K | 57.14%-3K |
Cash dividends paid | -0.46%-659K | -0.46%-659K | -0.30%-658K | 94.09%-2.63M | -0.46%-659K | -0.31%-656K | 96.96%-656K | 96.96%-656K | 48.42%-44.48M | 96.96%-656K |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --7.74M | ---- |
Net other financing activities | -13.99%-163K | --0 | -758.82%-292K | -100.44%-1.65M | ---9K | 99.87%-143K | 82.32%-1.46M | -100.01%-34K | 46,872.39%376.05M | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -5.53%-5.63M | -110.83%-5.18M | 12.18%-5.47M | -99.10%31.14M | -418.10%-5.1M | 98.03%-5.33M | 235.62%47.79M | -100.16%-6.22M | 2,836.25%3.47B | 100.82%1.6M |
Net cash flow | ||||||||||
Beginning cash position | 22.91%258.57M | 62.91%236.48M | 74.54%245.72M | 378.89%140.78M | 75.66%222.5M | -51.85%210.37M | -65.56%145.16M | 378.89%140.78M | 28.74%29.4M | 187.28%126.67M |
Current changes in cash | -47.57%6.36M | -66.12%22.09M | -311.14%-9.25M | -5.78%104.94M | 64.55%23.22M | 103.91%12.14M | 320.30%65.21M | -98.88%4.38M | 1,597.14%111.38M | 196.02%14.11M |
End cash Position | 19.07%264.93M | 22.91%258.57M | 62.91%236.48M | 74.54%245.72M | 74.54%245.72M | 75.66%222.5M | -51.85%210.37M | -65.56%145.16M | 378.89%140.78M | 378.89%140.78M |
Free cash flow | -199.45%-3.41M | 14.64%10.85M | 584.58%7.99M | -92.72%6.06M | -695.54%-8M | 251.64%3.43M | -61.04%9.46M | -97.94%1.17M | -24.76%83.25M | -93.82%1.34M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |